loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of Active Pharmaceutical Ingredients (APIs) supplied/manufactured by Dr. Reddy's Laboratories

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Abemaciclib (1)

02 Abiraterone Acetate (1)

03 Abiraterone Decanoate (1)

04 Acalabrutinib (1)

05 Adagrasib (1)

06 Alectinib Hydrochloride (1)

07 Amlodipine Besylate (1)

08 Apalutamide (1)

09 Apixaban (1)

10 Apremilast (1)

11 Atomoxetin Hydrochloride (1)

12 Atorvastatin (1)

13 Azacitidine (1)

14 Bempedoic Acid (1)

15 Bendamustine Hydrochloride (1)

16 Benztropine (1)

17 Bortezomib (1)

18 Brigatinib (1)

19 Cabazitaxel (1)

20 Cabozantinib S-Malate (1)

21 Canagliflozin (1)

22 Capecitabine (1)

23 Carfilzomib (1)

24 Cetirizine (1)

25 Cetirizine Dihydrochloride (1)

26 Cinacalcet Hydrochloride (1)

27 Clopidogrel (1)

28 Clopidogrel Besylate (1)

29 Clopidogrel Hydrochloride (1)

30 Dabigatran Etexilate Mesylate (1)

31 Dabrafenib Mesylate (1)

32 Dapagliflozin (1)

33 Dapagliflozin Propanediol Monohydrate (1)

34 Daprodustat (1)

35 Darolutamide (1)

36 Dasatinib (1)

37 Decitabine (1)

38 Desloratadine (1)

39 Deucravacitinib (1)

40 Dimethyl Fumarate (1)

41 Donepezil (1)

42 Doxazosin Mesylate (1)

43 Dutasteride (1)

44 Edaravone (1)

45 Edoxaban Tosylate (1)

46 Elagolix Sodium (1)

47 Eliglustat (1)

48 Enalapril Maleate (1)

49 Entrectinib (1)

50 Enzalutamide (1)

51 Eribulin (1)

52 Eslicarbazepine Acetate (1)

53 Esomeprazole Magnesium (1)

54 Eszopiclone (1)

55 Etrasimod (1)

56 Famotidine (1)

57 Ferric Maltol (1)

58 Fexofenadine Hydrochloride (1)

59 Fezolinetant (1)

60 Finasteride (1)

61 Finerenone (1)

62 Fingolimod Hydrochloride (1)

63 Fondaparinux Sodium (1)

64 Fosaprepitant (1)

65 Fruquintinib (1)

66 Gatifloxacin (1)

67 Gemcitabine (1)

68 Glimepiride (1)

69 Granisetron (1)

70 Hydroxychloroquine Sulphate (1)

71 Ibrutinib (1)

72 Iron Sucrose (1)

73 Ketorolac Trometamol (1)

74 Lacidipine (1)

75 Lenalidomide (1)

76 Lenvatinib Mesylate (1)

77 Levetiracetam (1)

78 Levocetirizine Dihydrochloride (1)

79 Levofloxacin Hemihydrate (1)

80 Lifitegrast (1)

81 Linagliptin (1)

82 Liraglutide (1)

83 Lomustine (1)

84 Losartan Potassium (1)

85 Lubiprostone (1)

86 Lumateperone Tosylate (1)

87 Lurasidone Hydrochloride (1)

88 Lurbinectedin (1)

89 Mavacamten (1)

90 Memantine Hydrochloride (1)

91 Metoprolol Succinate (1)

92 Midostaurin (1)

93 Mirabegron (1)

94 Mirogabalin Besilate (1)

95 Montelukast Sodium (1)

96 Moxifloxacin Hydrochloride (1)

97 Naproxen (1)

98 Naproxen Sodium (1)

99 Naratriptan Hydrochloride (1)

100 Nilotinib (1)

101 Niraparib Tosylate (1)

102 Nizatidine (1)

103 Olanzapine (1)

104 Omeprazole (1)

105 Omeprazole Magnesium (1)

106 Ondansetron (1)

107 Ondansetron Hydrochloride (1)

108 Osimertinib Mesylate (1)

109 Palbociclib (1)

110 Palonosetron (1)

111 Pantoprazole Sodium (1)

112 Pazopanib Hydrochloride (1)

113 Pemetrexed Disodium (1)

114 Perfluorohexyloctane (1)

115 Permethrin (1)

116 Pioglitazone Hydrochloride (1)

117 Pirtobrutinib (1)

118 Plerixafor (1)

119 Pomalidomide (1)

120 Posaconazole (1)

121 Pregabalin (1)

122 Quetiapine Hemifumarate (1)

123 Rabeprazole (1)

124 Raloxifene Hydrochloride (1)

125 Ramipril (1)

126 Ranolazine (1)

127 Relugolix (1)

128 Repaglinide (1)

129 Resmetirom (1)

130 Ribociclib (1)

131 Ripretinib (1)

132 Risperidone (1)

133 Ritlecitinib (1)

134 Rivaroxaban (1)

135 Rivastigmine Tartrate (1)

136 Ropinirole Hydrochloride (1)

137 Roxadustat (1)

138 Sacubitril-Valsartan (1)

139 Salcaprozate Sodium (1)

140 Semaglutide (1)

141 Siponimod (1)

142 Sitagliptin Hydrochloride (1)

143 Sitagliptin Malate (1)

144 Sitagliptin Phosphate (1)

145 Sugammadex Sodium (1)

146 Sumatriptan (1)

147 Tafamidis Meglumine (1)

148 Terbinafine Hydrochloride (1)

149 Testosterone (1)

150 Ticagrelor (1)

151 Tirzepatide (1)

152 Tizanidine HCl (1)

153 Tofacitinib Citrate (1)

154 Travoprost (1)

155 Treprostinil Diolamine (1)

156 Treprostinil Sodium (1)

157 Tucatinib (1)

158 Valsartan (1)

159 Varenicline Tartrate (1)

160 Venetoclax (1)

161 Voclosporin (1)

162 Vonoprazan Fumarate (1)

163 Voriconazole (1)

164 Ziprasidone Hydrochloride (1)

165 Zoledronic Acid (1)

filter

01 Dr. Reddy's Laboratories (165)

filter

01 India (165)

Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK &...
Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK & are inspected by international regulatory authorities on a regular basis. Its facilities are supplemented by formulation facilities that provide a wide range of dosage forms. "Product(s) under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act and not for commercial sale.”
Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK &...
Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK & are inspected by international regulatory authorities on a regular basis. Its facilities are supplemented by formulation facilities that provide a wide range of dosage forms. "Product(s) under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act and not for commercial sale.”
Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK &...
Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK & are inspected by international regulatory authorities on a regular basis. Its facilities are supplemented by formulation facilities that provide a wide range of dosage forms. "Product(s) under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act and not for commercial sale.”
URL Supplier Web Content
Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK &...
Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK & are inspected by international regulatory authorities on a regular basis. Its facilities are supplemented by formulation facilities that provide a wide range of dosage forms. "Product(s) under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act and not for commercial sale.”
Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK &...
Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK & are inspected by international regulatory authorities on a regular basis. Its facilities are supplemented by formulation facilities that provide a wide range of dosage forms. "Product(s) under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act and not for commercial sale.”
Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK &...
Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK & are inspected by international regulatory authorities on a regular basis. Its facilities are supplemented by formulation facilities that provide a wide range of dosage forms. "Product(s) under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act and not for commercial sale.”
Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK &...
Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK & are inspected by international regulatory authorities on a regular basis. Its facilities are supplemented by formulation facilities that provide a wide range of dosage forms. "Product(s) under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act and not for commercial sale.”
Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK &...
Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK & are inspected by international regulatory authorities on a regular basis. Its facilities are supplemented by formulation facilities that provide a wide range of dosage forms. "Product(s) under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act and not for commercial sale.”
Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK &...
Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK & are inspected by international regulatory authorities on a regular basis. Its facilities are supplemented by formulation facilities that provide a wide range of dosage forms. "Product(s) under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act and not for commercial sale.”
Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK &...
Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK & are inspected by international regulatory authorities on a regular basis. Its facilities are supplemented by formulation facilities that provide a wide range of dosage forms. "Product(s) under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act and not for commercial sale.”
Post Enquiry
POST ENQUIRY